Plante Moran Financial Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5
Closed 1019
2020
Q4
$0 Buy
+5
New +$459 ﹤0.01% 910
2018
Q2
Sell
-17
Closed -$1K 852
2018
Q1
$1K Buy
+17
New +$847 ﹤0.01% 890
2017
Q1
Sell
-141
Closed -$5K 909
2016
Q4
$5K Buy
141
+8
+6% +$240 ﹤0.01% 705
2016
Q3
$4K Buy
133
+26
+24% +$755 ﹤0.01% 733
2016
Q2
$3K Buy
107
+2
+2% +$78 ﹤0.01% 715
2016
Q1
$4K Buy
105
+54
+106% +$1.91K ﹤0.01% 612
2015
Q4
$2K Buy
+51
New +$1.78K ﹤0.01% 852

Other funds holding EBS

Plante Moran Financial Advisors's EBS Position: Q1 2021 in Review

Plante Moran Financial Advisors sold out of Emergent Biosolutions (EBS) in Q1 2021, closing a stake of 5 shares.

Plante Moran Financial Advisors first reported a position in EBS in Q4 2015 and held it in 7 quarters. The position peaked at $5K in Q4 2016. 340 funds tracked by Wall St. Rank hold EBS as of Q1 2021.

  • Plante Moran Financial Advisors reported no remaining Emergent Biosolutions position as of Q1 2021 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 5 Emergent Biosolutions shares in Q1 2021.
  • Plante Moran Financial Advisors first reported a position in Emergent Biosolutions in Q4 2015 and held it in 7 quarters.
  • Plante Moran Financial Advisors's Emergent Biosolutions position peaked at $5K in Q4 2016.
  • 340 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2021.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2021, filed 13 May 2021.